{"nct_id":"NCT02091752","title":"A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)","status":"TERMINATED","status_verified_date":"2016-02","start_date":"2014-09","start_date_type":null,"primary_completion_date":"2015-02","primary_completion_date_type":"ACTUAL","completion_date":"2015-02","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}